Target intelligence / Profile preview

SH3 domain-containing protein 21 (SH3D21)

Target
SH3D21
Molecular classification
Other (SH3 domain-containing protein; not assigned to major target classes like receptor, enzyme, transporter, ion channel, or transcription factor)
01

Overview

SH3 domain-containing protein 21 (SH3D21) is a human nuclear protein encoded by the SH3D21 gene on chromosome 1p34.3[1]. It contains three Src homology 3 (SH3) domains, typically known for mediating protein–protein interactions, especially recognizing proline-rich motifs[1][3][4]. While its precise function is not fully characterized, SH3D21 is predicted to be involved in protein complex assembly and cellular signaling. It is expressed at low levels in most tissues but shows high expression in certain neuronal ganglia. SH3D21 has two protein isoforms differing in the number of SH3 domains. Biological studies suggest potential links to actin filament organization and cell migration (especially from model organisms), and changes in SH3D21 expression have been observed in specific disease contexts, though direct causative roles remain unproven. No interacting drugs, biomarker roles, or notable safety concerns have been reported to date for this protein[1][2][4].

Other names
C1orf113FLJ22938SH3D21SH3 domain containing 21SH3 domain-containing protein C1orf113
02

Biological functions

Likely protein–protein interaction mediator (via its SH3 domains)Possible roles in actin filament organization and cell migration inferred from ortholog studies
03

Disease associations

Associated changes in expression noted in male infertility and in Ataxia Telangiectasia; chromosomal region linked to intracranial aneurysm and negative prognosis in colorectal cancer, but these associations are not direct evidence that SH3D21 is a disease driver

Beyond the preview

Go deeper on SH3 domain-containing protein 21 (SH3D21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SH3 domain-containing protein 21 (SH3D21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call